Wenbin Jiang - 22 Jul 2021 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Role
President and CEO, Director
Signature
/s/ Valerie Barnett, Attorney-in-Fact for Wenbin Jiang
Issuer symbol
CTKB
Transactions as of
22 Jul 2021
Transactions value $
$0
Form type
4
Filing time
26 Jul 2021, 21:46:55 UTC
Next filing
09 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTKB Stock Option (Right to Buy) Award $0 +250K $0.00 250K 22 Jul 2021 Common Stock 250K $17.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest as follows: 25% of the shares subject to the option vests on July 22, 2022; and 1/48th of the shares subject to the option vest monthly thereafter over the following three years.